News & EVENTS

 

 
 

SECONDMENTS TO EUROPE

May 2019

As part of mtFOIEGRAS Dr Hannah Rosa and PhD student Eliane de Menezes are off on secondment! Hannah is over in Lisbon for 2 weeks, back at Associação Protectora dos Diabéticos de Portugal and attending the EASD NAFLD and EGIR study group meetings.

Eliane will be spending 3 months at Mediagnost in Tubingen, Germany, to develop methods for evaluating mitochondrial dysfunction in NAFLD.

Picture1.png

MitoXT.png

upcoming event - MITOCHONDRIAL DNA AND DERIVED PEPTIDES IN HEALTH AND DISEASE

22nd October 2018

Dr Afshan Malik will be giving a talk on “Potential Mechanisms of Mitochondrial DNA mediated Acquired Mitochondrial Disease” at the Center for Neuroscience and Cell Biology, University of Coimbra, Portugal.

Find out more here


rise programme secondments in lisbon

September 2018

Dr Hannah Rosa has completed her 2-week secondment at Associação Protectora dos Diabéticos de Portugal working with Professor Paula Macedo to set up a collaboration looking at mitochondrial DNA copy number in patients with non-alcoholic liver disease (NAFLD).

Safa Khan has started her 3 month secondment at CEDOC - Chronic Diseases Research Center, New University of Lisbon, where she will be looking at mitochondrial dysfunction in mouse models of NAFLD and diabetes.

Good Luck with the rest of your secondment Safa!

RISA PROGRAM IMAGE.png

Kumar Sharma Talk.png

Professor Kumar Sharma Visits KCL

18th August 2018

Professor Sharma M.D. (Division of Nephrology, UT) visited the Diabetes department at King's for a brilliant talk on  Multi-Omics Analysis of Diabetic Kidney Disease. 


cONGRATULATIONS SAFA KHAN!

Safa, an MSc student who has been working in the lab since January, has submitted her dissertaion on "The impact of diabetes and diet induced non-alcoholic fatty liver disease (NAFLD) on liver mitochondrial DNA (MtDNA)". 


PISA 2018.png

RISE mTFOIEGRAS MIDTERM MEETING

PISA, iTALY

5th-8th July


Talks.png

52ND ANNUAL SCIENTIFIC MEETING OF THE
EUROPEAN SOCIETY FOR CLINICAL INVESTIGATION

Barcelona, Spain

30 May – 1 June 2018

Great talks from Dr Afshan Malik (The opposing impact of diabetes and Alzheimer's disease on brain mitochonrial DNA) and Dr Hannah Rosa (Detection of mitochondrial dysfunction in patients with diabetic kidney disease). 

Fantastic meeting organised by Dr Paulo Oliveira (Coimbra, Portugal), who will be next years host! 


Maria in the lab.jpg

Welcome Maria Joao Meneses!

From sunny Lisbon to sunny London, Maria is visiting on secondment from CEDOC - Chronic Diseases Research Center, New University of Lisbon for 3 months. Maria will be measuring MtDNA content in her NAFLD model as part of the ongoing mtFOIEGRAS RISE programme, funded by the EU.


European Diabetic Nephropathy Study Group (EDNSG)

Groningen, Netherlands

18th-19th May 2018

Dr Afshan Malik and Dr Hannah Rosa attend the annual EDNSG meeting in the beautiful city of Groningen! Great to hear an update on the interesting studies on human cohorts and biomarkers of diabetic kidney disease. Some very interesting mechanistic studies presented.


 
Photo from Hannah Rosa.jpg

Mitochondrial Medicine (Wellcome Genome Campus, Cambridge UK)

9th-11th May 2018

Lightning talk and poster: Evaluating diabetic complications as acquired mitochondrial disease.

Dr Afshan Malik presented a novel mechanism by which hyperglycemia-induced early systemic damage to MtDNA contributes to the development of diabetic complications, suggesting that diabetic complications could be considered as an acquired mitochondrial disease.


MitOX 2017 (University of OXFORD, UK)

1st December 2017

Poster presentation: Cell-free mitochondrial DNA in circulation in patients with diabetes and diabetic kidney disease.

Mitochondrial DNA (MtDNA), resembles bacterial DNA and is largely un-methylated. If damaged it can accumulate outside the mitochondria and elicit an inflammatory response via activation of the TLR9 pathway. We recently reported that patients with diabetes (DC) had increased MtDNA in whole blood compared to healthy controls (HC). Conversely, patients with diabetic nephropathy (DN) had lower MtDNA than DC patients. The objective of the current study is to determine if changes to MtDNA content seen in patient whole blood samples are due to alterations in circulating, cell-free MtDNA or increased cellular MtDNA in blood cells.

Click image to enlarge


IMG_3291-Tubingen Rise meeting oct 2017.jpg

RISE networking MEETING (Tübingen, Germany) 

9-10th October 2017

Mediagnost and Microbiolytics, (Germany) hosted a project networking meeting to bring together representatives of mtFOIE GRAS (RISE) projects partners. This meeting aimed at facilitating the collaboration and knowledge sharing among project beneficiaries and at creating synergies for effective project implementation and coordinated results. All project representatives worked to identify common ground for collaboration and actions were agreed upon for the upcoming secondments among partners. The meeting was overall positively perceived by the participants who made constructive recommendations and requested that meetings of this type recur in the future.

After the networking meeting participants had a wonderful chance to enjoy the beautiful scenery of Tübingen in Germany. (Source mtFOIECRAS)


53rd Annual Meeting of the European Association for the Study of Diabetes (Lisbon, Portugal)

11-15th September 2017

Poster presentation: Diabetes induced changes in circulating and kidney mitochondrial DNA: a potential novel pathway of renal damage.

We recently showed that circulating mitochondrial DNA (MtDNA) levels are an independent risk marker in patients with diabetic nephropathy (DN) and proposed that diabetes induced early systemic changes in MtDNA may be involved in DN. To test this hypothesis, in the current study we investigated the early effect of diabetes on circulating and renal MtDNA levels in the Streptozotocin (STZ) induced diabetic mouse model.

Click image to enlarge


Previous meetings 

Spain (Sitges), Sept, 2015. European Molecular Biology Organisation (EMBO). Workshop on “Mitochondrial DNA and neurodegeneration”.

AN Malik Changes in mitochondrial DNA as an early indicator of mitochondrial and metabolic dysfunction.

EB Thubron, A Hodges, S. Sivaprasad, AN Malik  Altered mitochondrial DNA content in diabetic and Alzheimer brains.  EBT received a full scholarship from the organisers

USA (Tampa, Florida) Sept 2015, Conference “Translation Bioenergetics”, organised by the American Physiological Society,

AN Malik “Mitochondrial DNA content: accurate measurement and evaluation as an early biomarker of mitochondrial Dysfunction” Invited talk 

Saima Ajaz, Anna Czajka, Luigi Gnudi, Afshan Malik.  Mitochondrial DNA changes and dysfunction in diabetic nephropathy. Poster,   SA won a scholarship and an award from APS

Anna Czajka and AN.Malik Diabetes induced alterations in cellular bioenergetics in renal cell lines. Poster AC won a scholarship and an award from APS

Romania (Cluj-Napoca), May 2015, Annual Meeting of the European Society of Clinical Investigation held at Cluj Napoca,

AN Malik “Mitochondrial DNA, friend or foe” Plenary invited talk

AN Malik “Mitochondrial dysfunction in diabetic nephropathy” Invited talk for Mitochondrial workshop

Denmark (Copenhagen) May 2015, European Diabetic Nephropathy Study Group, annual conference, Copenhagen,

AN Malik “Mitochondrial dysfunction in diabetic nephropathy” Oral selected presentation

UK (Liverpool) March 2015 Diabetes UK Annual Professional Conference, 

S Ajaz, A Czajka, L Gnudi, PM Jones, AN Malik  “Changes in circulating mitochondrial DNA content in diabetes patients are not accompanied by increased transcription of mitochondrial genes” Diabetic Medicine,  32: 32,  poster,  Diabetes UK, Liverpool. SA won DUK scholarship

A Czajka, S Ajaz, P Jones, AN Malik. 2015 Hyperglycaemia-induced changes in mitochondrial DNA in primary cultured mesangial cells are not accompanied by increased transcription of mitochondrial genes, Diabetic Medicine, 32, 32-32. poster                

EB Thubron, A Czajka, AN Malik. 2014 The effect of hyperglycaemia on mitochondria in the diabetic brain. Diabetic Medicine. 31:35-35, poster

S Mirzaei, AN Malik. 2014 “An investigation of the expression of mu-crystallin (CRYM) in diabetic nephropathy” , Diabetic Medicine 31:58-58, poster               

South Africa (Potchefstroom) Nov 2014. Mitochondrial DNA workshop in South Africa funded by the Royal Society/SAMRC,

AN Malik “The role of mitochondrial DNA changes in diabetic complications: translational aspects” invited talk.

Portugal (Coimbra), Dec 2014, the Portuguese Biochemical Society meeting,

 Afshan Malik The role of mitochondrial DNA in the loss of mitochondrial bio-energetic flexibility.  Invited talk

France (Bordeaux), October 2014, conference on “Mitochondrial functions and dysfunction in the central nervous system (MITOBRAIN)”  

EB. Thubron, A. Hodges, S. Sivaprasad, AN Malik,2014 Quantification of mitochondrial DNA in diabetes and Alzheimer’s disease”,  poster and presentation at the The organisers awarded a full bursary to EBT.

Finland (Tampere), June 2014,  EUROMIT (International meeting on mitochondrial pathology)  

16.A.Czajka and AN Malik “Hyperglycemia-induced changes in mitochondrial DNA and function in cultured renal cells and mouse models of diabetes”  ,  Poster presentation at Euromit June, 2014,  Tampere, Finland

E.Thubron, A.Hodges, S. Sivaprasad and AN Malik. Quantification of circulating mitochondrial DNA in patients with Alzheimer’s disease” Poster presentation at Euromit  June, 2014,  Tampere, Finland

“Changes in mitochondrial DNA in patients with diabetic nephropathy” Saima Ajaz, Luigi Gnudi, Peter Jones and Afshan Malik, Poster presentation at Euromit June  2014,  Tampere, Finland

.Quantification of circulating mitochondrial DNA in patients with Alzheimer’s disease” Elisabeth Thubron, Angela Hodges, Sobha Sivaprasad and Afshan Malik , Poster presentation at Euromit 2014,  Tampere, Finland

Saima Ajaz, Luigi Gnudi, Peter Jones and Afshan Malik “The role of  mitochondrial DNA in patients with diabetic nephropathy”, Oral presentation at the 16th European Diabetic Nephropathy Study Group, Royal College of Surgeons, London UK

UK (Cambridge) May 2014 Seahorse Users group meeting,

.AN Malik “Altered Mitochondrial Function in Diabetic Nephropathy” Featured talk.

UK (London), May 2014  European Study group for Diabetic Nephropathy annual conference,

 Anna Czajka and A N Malik Hyperglycemia induced alterations in mitochondrial DNA content and mitochondrial respiration in human glomerular mesangial cells.  Poster

Altered mitochondrial DNA content in blood and urine of patients with diabetic nephropathy. Saima Ajaz, Luigi Gnudi, Peter Jones and Afshan Malik. Oral selected presentation

UK (London), March 2014, Diabetes UK professional conference

.A Czajka, AN Malik “ Mitochondrial dysfunction in diabetic nephropathy” Diabetic Medicine 31:58-58   

S Ajaz, L Gnudi, A Czajka, PM Jones, AN Malik 2014” Altered mitochondrial DNA content in blood and urine of patients with diabetic nephropathy”  Diabetic Medicine 31: 58-58           

A Czajka, P Jones, AN Malik 2013 “Hyperglycaemia-induced alterations in mitochondrial DNA content in cultured human glomerular mesangial cells”

Germany (Berlin), Nov 2013, 4rth  world congress on Targeting mitochondria, Berlin.

Afshan Malik, "Damaged Mitochondrial DNA, a Novel Putative Target for Treatment of Diabetic Complications and Other Diseases of Mitochondrial Dysfunction" invited featured speaker.

France (Paris), October 2013,  International Scoiety for Nutrition and Health conference on Antioxidants

.Anna Czajka and A N Malik . Accurate quantification of Mitochondrial DNA, a biomarker of mitochondrial dysfunction and oxidative stress.. Oral presentation

Denmark. Copenhagen,  Mitochondria in Physiology Summer  2013 School, Saima Ajaz and Afshan Malik, “Measuring mitochondrial DNA content in human blood” oral presentation . Portugal (Albufeira) April 2013, meeting on “Mitochondrial Physiology” organised by European Society Clinical Investigation.

.Afshan Malik, “Circulating Mitochondrial DNA as a biomarker of mitochondrial dysfunction” invited talk,

Spain (Barcelona) May 2013 Annual Meeting of the European Diabetic Nephropathy Study Group

Afshan Malik, Sabine Landau and Luigi Gnudi  “Increased mitochondrial DNA in patients with albuminura” oral presentation

Anna Czajka and A N Malik, Hyperglycemia induced alterations in mitochondrial DNA content and mitochondrial function in cultured human glomerular mesangial cells  Poster presentation

Saima Ajaz,  Anna Czajka, Luigi Gnudi, Saman Mirzaei, Peter Jones and Afshan Malik “ An investigation of mitochondrial biogenesis in circulating cells of patients with diabetic nephropathy” Poster presentation

UK (Manchester) March 2013 Diabetes UK professional conference

 Anna Czajka and A N Malik Hyperglycemia induced alterations in mitochondrial DNA content in cultured human glomerular mesangial cells , ,  Poster presentation at, Manchester, UK 2013

AN Malik, S Landau, L Gnudi 2013 “Circulating mitochondrial DNA content is associated with albuminuria in patients with diabetic nephropathy” Diabetic Medicine 30:71-71                

Ajaz, A Czajka, S Mirzaei, L Gnudi, P Jones, AN Malik 2013”An investigation of mitochondrial biogenesis in circulating cells of patients with diabetic nephropathy”. Diabetic Med. 30: 64-64

Chile (Santiago) Jan 2013 Unveiling Mitochondria meeting

Anna Czajka and A N Malik, The role of alternations in mitochondrial DNA content in circulating blood and renal cells in diabetes and diabetic nephropathy.  Presented at, Poster and oral presentation, AC received full scholarship a for this prestigious meeting